SciELO - Scientific Electronic Library Online

 
vol.19 issue5Primary antiphospholipid syndrome: characteristics and evolution of a series of 17 casesDisseminated cytomegalovirus infection in immunocompetent patients author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Anales de Medicina Interna

Print version ISSN 0212-7199

Abstract

MONTES SANTIAGO, J. et al. Progressive Multifocal Leukoencephalopathy in AIDS patients: any change in the highly active antiretrovial therapies era?. An. Med. Interna (Madrid) [online]. 2002, vol.19, n.5, pp.20-23. ISSN 0212-7199.

Aims: Progressive multifocal leukoencephalopathy (PML) develops in up to 4-8% of all AIDS patients. Before highly active antiretroviral therapies (HAART) the median survival was only 4-6 months. In this study we analyzed epidemiological parameters in AIDS-related LMP patients in search for differences in the incidence and prognosis between before and after HAART era. Mehods : Retrospective review of clinical histories of patients diagnosed of AIDS and PML at Hospital Meixoeiro in Vigo, Spain, between 01/01/94-31/05/97 (Before-HAART period) and 01/06/97-30/04/00 (After-HAART period). PML was diagnosed by clinical and neuroimaging criteria, with biopsy in 2 cases and positive JC virus hibridation in CSF in another case.  Results: We identified 12 patients (global prevalence of 3.8%, without differences between periods): 11 males, 10 intravenous drugs users (IDU), mean age of 38 years (31-43). In 6, LMP was the first opportunistic infection. When PML was diagnosed, 6 patients had a HIV viral load (VL)250.000 copies of RNA/ml (range, 254.000-3.170.000), and overall a mean CD4 lymphocytes counts of 89 x 10 6/ml (40-134). Three patients received cytarabine+Interferon with zidovudine (2 patients) and zidovudine+lamivudine (1 patient) and other patient HAART+cidofovir, but no improvement was observed. The median survival was 10 months in before-HAART group and 17 months in after-HAART group, with a survival 48 months in 2 patients in the last group. Conclusions: LMP is observed in severely immunosuppressed IDU men (VLlog 5 copies RNA/ml and CD4<150 x106/ml). Complementary treatments were ineffective and only in patients with HAART a prolonged survival was observed.

Keywords : Progressive multifocal leukoencephalopathy; AIDS; JC virus.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License